Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

UnitedHealth is scheduled to report its Q2 earnings on July 29th. Jim Cramer recommends against buying UNH shares until then.

Evernorth Health Services appointed Prashanti Reddy Bodugum as Head of its Hyderabad Innovation Hub. With 26 plus years of ...

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

AbbVie, Merck & Co., Inc., UnitedHealth Group, Hims & Hers Health, and Insmed are the five Medical stocks to watch today, ...

Historically dominated by physician owners, ASCs are now seeing rising involvement from hospitals, private equity firms and even payers. Shobhit Minhas, MD, orthopedic surgeon at Fox Valley ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...